Administration of the AAV-based central cell-binding domain and C-terminal heparin-binding domain (CBD-Hep II) recombinant polypeptide of human fibronectin suppresses the growth and spontaneous metastasis of breast carcinoma, and prolongs the survival of tumor-bearing mice [86]